RELATED FUNDING OPPORTUNITIES & UPDATES TO FUNDING:
FEDERAL FUNDING & UPDATES |
Grant Name: | |
Summary: | Seeks research pertaining to host response, associations with heart, lung, and blood diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals. |
Dates: | 10/5/20 |
Grant Name: | Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) |
Summary: | Seeks research for an array of medical countermeasures to diagnose, treat, or protect against COVID-19. |
Dates: | 10/31/20 |
Grant Name: | |
Summary: | Seeks projects to develop predictive models for disease spread; tools for rapid detection; and rapid development of therapeutic agents. |
Dates: | 2/5/21 |
Grant Name: | |
Summary: | A potential request for project proposals for technologies such as point-of-care testing, therapeutics, and patient tracking systems. |
Dates: | Projected mid-2020 |
Grant Name: | |
Summary: | Invites RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. |
Dates: | Varies by NSF program |
Grant Name: | |
Summary: | As the charitable foundation for the American College of Chest Physicians, the CHEST Foundation has a mission of championing lung health by supporting clinical research, patient education, and community service. Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19. Grants are $25,000. |
Dates: | Proposals are due by July 17, 2020. |
FOUNDATIONS / CORPORATE FUNDING & UPDATES |
Grant Name: | Gilead COVID-19 Unmet Medical Needs and Associated Research Extension |
Summary: | Through this program, Gilead will consider support for research proposals that meet one of the following criteria pertaining to COVID-19: Expand data on clinical course and outcome in vulnerable populations; Long-term sequelae (i.e., pulmonary fibrosis, neurologic, cardiac, quality of life); and Real world safety and effectiveness of remdesivir used alone or with other agents (JAK inhibitors, IL-6 inhibitors, convalescent plasma and ACE inhibitors and ARBs). Grants are up to $250,000. |
Dates: | LOIs are due by August 3, 2020. |
Grant Name: | |
Summary: | RSF is funding research on the Covid-19 pandemic and the resulting recession in the U.S.; specifically, research that assesses the social, political, economic, and psychological causes and consequences of the pandemic, especially its effects on marginalized individuals and groups and on trust in government and other institutions (excluding health outcomes). RSF is also interested in research focused on systemic racial inequality and/or the recent mass protests in the United States. |
Dates: | Proposals are due by August 5, 2020. |
RESEARCH DEVELOPMENTS & RELATED ARTICLES
New White House Rules Restrict Use of Grant Funding to Deal With COVID-19 Impacts: New rules on how U.S. universities manage federal research grants leave them with less flexibility to cope with the pandemic.
Learn from the Pandemic to Prevent Environmental Catastrophe, Scientists Argue: The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.
COVID Risk Levels Dashboard: Provides state and county-level risk assessments related to COVID-19. Risk levels are based on daily cases per 100,000 population, using a 7 day moving average. Also includes data on case counts and deaths. Sponsored by Harvard Global Health Institute.
U.S. COVID Atlas: Provides county-level data on COVID-19 cases and deaths, with the option to view regional clusters and to overlay the map with Native American reservations. Map and related chart can be animated to show changes over time from January 2020 through the present. Sponsored by University of Chicago Center for Spatial Data Science.
Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities ― United States, April-May 2020: Provides data from 28 states on the number of meat and poultry processing facilities affected by COVID-19, characteristics of affected workers, and COVID-19–associated deaths among workers. Data on cases and deaths through May 31, 2020 were obtained from 239 affected facilities. Also describes interventions and prevention efforts at these facilities.